JP2009531457A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009531457A5 JP2009531457A5 JP2009503206A JP2009503206A JP2009531457A5 JP 2009531457 A5 JP2009531457 A5 JP 2009531457A5 JP 2009503206 A JP2009503206 A JP 2009503206A JP 2009503206 A JP2009503206 A JP 2009503206A JP 2009531457 A5 JP2009531457 A5 JP 2009531457A5
- Authority
- JP
- Japan
- Prior art keywords
- agents
- buffers
- antioxidants
- stabilizers
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
Description
本発明は、さらに、活性成分としての本発明の化合物が分解する速度を低下させる１種以上の薬剤を含む医薬組成物および投与形態に関する。ここでは“安定化剤”と呼ぶこのような薬剤は、アスコルビン酸のような抗酸化剤、ｐＨ緩衝剤、または塩緩衝剤などを含み、これらに限定されない。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78710406P | 2006-03-29 | 2006-03-29 | |
| US60/787,104 | 2006-03-29 | ||
| PCT/US2007/064974 WO2007117982A2 (en) | 2006-03-29 | 2007-03-27 | Organic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009531457A JP2009531457A (ja) | 2009-09-03 |
| JP2009531457A5 true JP2009531457A5 (ja) | 2010-04-22 |
| JP5197569B2 JP5197569B2 (ja) | 2013-05-15 |
Family
ID=38477291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009503206A Expired - Fee Related JP5197569B2 (ja) | 2006-03-29 | 2007-03-27 | 有機化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8153674B2 (ja) |
| EP (2) | EP2001866A2 (ja) |
| JP (1) | JP5197569B2 (ja) |
| KR (1) | KR20080114769A (ja) |
| CN (1) | CN101410389A (ja) |
| AU (1) | AU2007234968A1 (ja) |
| BR (1) | BRPI0709678A2 (ja) |
| CA (1) | CA2644391A1 (ja) |
| ES (1) | ES2442347T3 (ja) |
| MX (1) | MX2008012402A (ja) |
| RU (1) | RU2008142600A (ja) |
| WO (1) | WO2007117982A2 (ja) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101119969B (zh) | 2004-07-15 | 2014-04-09 | 阿尔巴尼分子研究公司 | 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和血清素的重摄取的应用 |
| WO2008076860A1 (en) * | 2006-12-18 | 2008-06-26 | Novartis Ag | 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| CA2672269A1 (en) * | 2006-12-18 | 2008-06-26 | Novartis Ag | Organic compounds |
| EP2095819A1 (en) | 2008-02-28 | 2009-09-02 | Maastricht University | N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| ES2446971T3 (es) | 2009-05-12 | 2014-03-11 | Albany Molecular Research, Inc. | Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso |
| ES2662072T3 (es) | 2009-05-12 | 2018-04-05 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y uso de la misma |
| ES2528404T3 (es) | 2009-05-12 | 2015-02-10 | Bristol-Myers Squibb Company | Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos |
| CN103958478B (zh) * | 2011-11-30 | 2017-08-01 | 霍夫曼-拉罗奇有限公司 | 双环二氢异喹啉‑1‑酮衍生物 |
| JP6382108B2 (ja) * | 2011-11-30 | 2018-08-29 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 新規二環式ジヒドロイソキノリン−１−オン誘導体 |
| EP2639212B1 (en) | 2012-03-13 | 2016-03-09 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Enantioselective organic anhydride reactions |
| TWI600658B (zh) * | 2014-07-24 | 2017-10-01 | 百靈佳殷格翰國際股份有限公司 | 醛固酮合成酶抑制劑 |
| EP3250569B1 (en) * | 2015-01-30 | 2019-01-09 | Boehringer Ingelheim International GmbH | Aldosterone synthase inhibitors |
| BR112019018700A2 (pt) | 2017-03-10 | 2020-04-07 | Embera Neurotherapeutics Inc | composições farmacêuticas e seus usos |
| CN109232607A (zh) * | 2018-09-20 | 2019-01-18 | 沈阳药科大学 | 劳拉替尼的合成方法 |
| WO2020223267A1 (en) | 2019-05-01 | 2020-11-05 | Boehringer Ingelheim International Gmbh | (r)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0305332A3 (de) * | 1987-08-26 | 1990-04-04 | Ciba-Geigy Ag | Imidazol-Derivate |
| DE102004035322A1 (de) * | 2004-07-21 | 2006-02-16 | Universität des Saarlandes | Selektive Hemmstoffe humaner Corticoidsynthasen |
-
2007
- 2007-03-27 AU AU2007234968A patent/AU2007234968A1/en not_active Abandoned
- 2007-03-27 RU RU2008142600/04A patent/RU2008142600A/ru not_active Application Discontinuation
- 2007-03-27 JP JP2009503206A patent/JP5197569B2/ja not_active Expired - Fee Related
- 2007-03-27 CA CA002644391A patent/CA2644391A1/en not_active Abandoned
- 2007-03-27 CN CNA2007800110014A patent/CN101410389A/zh active Pending
- 2007-03-27 EP EP07759422A patent/EP2001866A2/en not_active Withdrawn
- 2007-03-27 EP EP10179603.5A patent/EP2301931B1/en not_active Not-in-force
- 2007-03-27 MX MX2008012402A patent/MX2008012402A/es not_active Application Discontinuation
- 2007-03-27 ES ES10179603.5T patent/ES2442347T3/es active Active
- 2007-03-27 BR BRPI0709678-0A patent/BRPI0709678A2/pt not_active Application Discontinuation
- 2007-03-27 WO PCT/US2007/064974 patent/WO2007117982A2/en active Application Filing
- 2007-03-27 KR KR1020087023643A patent/KR20080114769A/ko not_active Application Discontinuation
- 2007-03-27 US US12/295,155 patent/US8153674B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009531457A5 (ja) | ||
| CA3148745A1 (en) | Kras g12d inhibitors | |
| WO2013066835A3 (en) | Compounds and methods | |
| WO2013066839A3 (en) | Compounds and methods | |
| NZ602557A (en) | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
| MX2009000285A (es) | Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas. | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| EA201101192A1 (ru) | Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов | |
| GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
| MA32774B1 (fr) | Antagonistes de récepteur de mélanocortine | |
| MX2010007677A (es) | Derivados de hidroximoil-tetrazol como fungicidas. | |
| WO2008061724A3 (en) | Compositions comprising carnosic acid 12-methylether | |
| JO2973B1 (en) | Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| MX2014013851A (es) | Composiciones farmaceuticas topicas que comprenden terbinafina y urea. | |
| WO2007009701A3 (en) | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome | |
| WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
| WO2014064652A3 (en) | Stable pharmaceutical composition of peginterferon alpha-2b | |
| WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
| PT1981862E (pt) | Compostos relacionados com lantionina para o tratamento de doenças inflamatórias | |
| ATE548043T1 (de) | Polymorphe von 3-o-(3',3'- dimethylsuccinyl)betulinsäure-di-n-methyl-d- glucamin | |
| MY152044A (en) | Adiponectin for treating pulmonary disease | |
| WO2010094452A3 (en) | Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms | |
| WO2009097973A3 (de) | Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel |